Country: South Africa
Language: English
Source: South African Health Products Regulatory Authority (SAHPRA)
Lennon
CYCLIVEX 200 mg TABLETS SCHEDULING STATUS: S4 PROPRIETARY NAME (and dosage form): CYCLIVEX 200 mg TABLETS COMPOSITION: Each tablet contains: Acyclovir 200 mg as active ingredient PHARMACOLOGICAL CLASSIFICATION: A 20.2.8 - Antiviral agents PHARMACOLOGICAL ACTION: Acyclovir is active in vitro against Herpes simplex virus (HSV) types I and II and varicella-zoster virus. This activity is due to intracellular conversion of acyclovir to acyclovir triphosphate by viral thymidine kinase. Acyclovir triphosphate inhibits viral DNA synthesis and replication. INDICATIONS: - Treatment of initial and recurrent Herpes simplex infections of the skin and mucous membranes including initial and recurrent genital Herpes simplex infections. - Suppression of recurrent genital Herpes simplex infections in immunocompetent patients. - Prophylaxis of Herpes simplex infections in immuno-compromised patients. - Treatment of Herpes zoster infections if the lesions are not older than 72 hours. - Treatment of Varicella zoster (chickenpox) within 24 hours after appearance of the typical chickenpox rash. CONTRA-INDICATIONS: Acyclovir tablets are contra-indicated in patients known to be hypersensitive to acyclovir. The safety of acyclovir in pregnancy has not been established. Acyclovir should not be administered to pregnant women or nursing women as acyclovir passes into breast milk. DOSAGE AND DIRECTIONS FOR USE: DOSAGE IN ADULTS For treatment of initial and recurrent Herpes simplex infections of the skin and mucous membranes: 200 mg acyclovir should be taken 5 times per day at approximately four hourly intervals omitting the night time dose. Treatment should continue for 5 days, but in a case of severe initial infection the treatment period may have to be extended. In severely immunocompromised patients e.g. after Read the complete document